ArticleParasites & vectors2026
Investigation of neglected bacterial pathogens provides molecular and serological evidence of Bartonella spp. in patients with acute undifferentiated febrile illness in Villeta, Colombia.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAcute undifferentiated febrile illness (AUFI) is a challenging clinical condition in tropical regions, caused by a broad range of pathogens. In Villeta municipality, Colombia, data on neglected bacterial causes remain scarce, highlighting the need to expand understanding of the local etiological spectrum. Thus, the aim of the present study was to explore the presence of the neglected pathogens, Bartonella, Borrelia, and Coxiella burnetii, as potential causes of AUFI in Villeta.
methodsDNA was extracted from whole-blood samples from febrile patients. Quality and purity were assessed spectrophotometrically and by conventional polymerase chain reaction (PCR). Bartonella, Borrelia, and C. burnetii were detected using genus- and species-specific quantitative PCR (qPCR) assays. Bartonella-positive samples were further analyzed by multigene PCRs and sequencing for species identification. Anti-Bartonella and anti-C. burnetii immunoglobulin G (IgG) antibodies were evaluated by indirect immunofluorescence to assess recent or past exposure to these agents.
resultsA total of 41 febrile patients were evaluated. Bartonella DNA was detected in 9.8% (4/41) of samples. No Borrelia or C burnetii DNA was detected. Phylogenetic analysis revealed two distinct clades, although none could be assigned to species level. Serological analysis showed anti-Bartonella IgG antibodies in 29.3% (12/41) of cases, with 9.8% (4/41) exhibiting seroconversion. One patient presented both molecular and seroconversion evidence of recent Bartonella infection. None of the patients were seropositive for C. burnetii.
conclusionsThis study provides the first molecular and serological evidence of Bartonella circulation among febrile patients in Villeta, Colombia, revealing genetically distinct lineages and indicating both active and past infections, underscoring its potential role in AUFI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.